Insights on Insulin Injection Preferences by Pan India Doctors

Insights on Insulin Injection Preferences by Pan Doctors India. Today, approximately 100 million people around the world need insulin, including all people living with type 1 diabetes and between 10-25 percent of people with type 2 diabetes. Although insulin has been used in the treatment of diabetes for over 90 years, globally more than half of those who need insulin still have difficulties accessing it. Without insulin, people living with type 1 diabetes will die.

We have conducted a short survey through a Doctor for Insulin, from the responses we have got we have made some analysis on it.

Some Insights on Insulin Injection Preferences by Pan Doctors India:

The Doctor’s response about which insulin injection brand, they recommend in a patient with type 2 Diabetes mellitus is “Human Mixtard 30/70 100IU INJ 10ml”.

However, 6 to 7% of Doctors Also Prescribe “Insugen 30/70 INJ Refill Box 5/*3ml” and “Recosulin M30/70 40IU INJ 10ml”

The above analysis gives you the proper understanding of which insulin brand Doctors preferred the most. The brand/injection to compete within all cases for Type 2 Diabetes Mellitus is Human Mixtard 30/70 100 IU INJ 10ml.

Insulin combinations are mostly fast-acting or short-acting insulin with a longer-acting insulin, typically an NPH insulin. The combination products begin to work with the shorter-acting insulin (5–15 minutes for fast-acting, and 30 minutes for short acting) and remain active for 16 to 24 hours. There are several variations with different proportions of the mixed insulins.

When we compared the most popular combination of Human Insulin 30% + NPH Human Insulin we realized that the awareness for Human Mixtard, Insugen, and Recosulin combinations are high but Human Mixtard is the most preferred.

We recommend Brands focus as much as possible to drive awareness about unique Inj. Combinations or keep Doctors aware of the most preferred Human Insulin + NPH Combination.

When we look at the exact purpose of controlling Blood Sugar in Adults and Children with Diabetes, we realized that although multiple Inj. Brands are available the most popular by choice has been Mixtard. Moreover, although all the Inj. Have similar or in many cases same combinations the preference of Mixtard supersedes similarities.

The major reason has been for the longest time Mixtard has been awareness – Mixtard has been a brand of choice and excellent brand recall through a decade and Pan India across Geographies.

Conclusion:

For all companies looking at marketing Insulin Inj. we highly recommend digitally focus on insulin combination benefits vis a vis comparison on Human Mixtard. The more similarity, the more will be the brand acceptability.
For the current marketing team of Mixtard, we recommend digitally reinforce the Mixtard brand value proposition not only educationally but also through promotional/animated videos and infographics that reinforce brand recall. We hope you enjoyed reading Insights on Insulin Injection Preferences by Pan Doctors India.

To see our entire list of articles click here.

About Hidoc Dr:
Our company Hidoc Dr. is a Digital Platform for Doctors with an audited reach of 4.2 Lakh Doctors across India. Hidoc Dr. provides Digital Marketing services to your brands to reach Doctors across all Specializations and Geographies. Hidoc Digital Solutions guarantee 3x Brand Recall compared to any other digital solutions today.

You can reach out to us at varun@hidoc.co or aditi@hidoc.co or call us at +917218436858 to learn more.

RELATED READ:

1. What are Obstetrics, Gynecologist and IVF searching and reading on Digital Platforms?
2. What is Paediatrics searching and reading on Digital Platforms?
3. What are Intensivists searching and reading on Digital Platforms?